The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Drug Delivery Devices-Global Market Insights and Sales Trends 2025
Synopsis
Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.
The global Drug Delivery Devices market size is expected to reach US$ 58080 million by 2029, growing at a CAGR of 4.9% from 2023 to 2029. The market is mainly driven by the significant applications of Drug Delivery Devices in various end use industries. The expanding demands from the Pharmaceutical Companies, Hospitals, Clinics and Other, are propelling Drug Delivery Devices market. Injection Type, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Mucosal Type segment is estimated at % CAGR for the next seven-year period.
The top five global manufacturers of drug delivery equipment are Cipla, Baxter International, Nipro Corporation, Roche and Boehringer Ingelheim, with a combined market share of 29 per cent. North America, which has a well-established healthcare infrastructure and a large number of leading pharmaceutical and biopharmaceutical companies (around 80% of the world's research and development in biopharmaceutical is conducted by US-based firms), is the largest market for drug delivery, about for 47% followed by Europe with 28%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drug Delivery Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drug Delivery Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drug Delivery Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drug Delivery Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drug Delivery Devices covered in this report include Cipla, Baxter International, Nipro Corporation, Roche, Boehringer Ingelheim, Allergan, 3M, BD and Catalent, etc.
The global Drug Delivery Devices market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cipla
Baxter International
Nipro Corporation
Roche
Boehringer Ingelheim
Allergan
3M
BD
Catalent
Valeant Pharmaceuticals
Bayer AG
Chiesi
Phillips-Medisize
Johnson & Johnson
Shandong Weigao
Pfizer
B.Braun
Novartis AG
Zhengkang
Gerresheimer
COVIDIEN Medtronic
Schott forma vitrum
Alkermes
Skyepharma
Global Drug Delivery Devices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug Delivery Devices market, Segment by Type:
Injection Type
Mucosal Type
Implanted Type
Others Type
Global Drug Delivery Devices market, by Application
Pharmaceutical Companies
Hospitals
Clinics
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Drug Delivery Devices companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.
The global Drug Delivery Devices market size is expected to reach US$ 58080 million by 2029, growing at a CAGR of 4.9% from 2023 to 2029. The market is mainly driven by the significant applications of Drug Delivery Devices in various end use industries. The expanding demands from the Pharmaceutical Companies, Hospitals, Clinics and Other, are propelling Drug Delivery Devices market. Injection Type, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Mucosal Type segment is estimated at % CAGR for the next seven-year period.
The top five global manufacturers of drug delivery equipment are Cipla, Baxter International, Nipro Corporation, Roche and Boehringer Ingelheim, with a combined market share of 29 per cent. North America, which has a well-established healthcare infrastructure and a large number of leading pharmaceutical and biopharmaceutical companies (around 80% of the world's research and development in biopharmaceutical is conducted by US-based firms), is the largest market for drug delivery, about for 47% followed by Europe with 28%.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Drug Delivery Devices, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Drug Delivery Devices market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Drug Delivery Devices market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Drug Delivery Devices sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Drug Delivery Devices covered in this report include Cipla, Baxter International, Nipro Corporation, Roche, Boehringer Ingelheim, Allergan, 3M, BD and Catalent, etc.
The global Drug Delivery Devices market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Cipla
Baxter International
Nipro Corporation
Roche
Boehringer Ingelheim
Allergan
3M
BD
Catalent
Valeant Pharmaceuticals
Bayer AG
Chiesi
Phillips-Medisize
Johnson & Johnson
Shandong Weigao
Pfizer
B.Braun
Novartis AG
Zhengkang
Gerresheimer
COVIDIEN Medtronic
Schott forma vitrum
Alkermes
Skyepharma
Global Drug Delivery Devices market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drug Delivery Devices market, Segment by Type:
Injection Type
Mucosal Type
Implanted Type
Others Type
Global Drug Delivery Devices market, by Application
Pharmaceutical Companies
Hospitals
Clinics
Other
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Drug Delivery Devices companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Drug Delivery Devices
1.1 Drug Delivery Devices Market Overview
1.1.1 Drug Delivery Devices Product Scope
1.1.2 Drug Delivery Devices Market Status and Outlook
1.2 Global Drug Delivery Devices Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Drug Delivery Devices Market Size by Region (2018-2029)
1.4 Global Drug Delivery Devices Historic Market Size by Region (2018-2023)
1.5 Global Drug Delivery Devices Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Drug Delivery Devices Market Size (2018-2029)
1.6.1 North America Drug Delivery Devices Market Size (2018-2029)
1.6.2 Europe Drug Delivery Devices Market Size (2018-2029)
1.6.3 Asia-Pacific Drug Delivery Devices Market Size (2018-2029)
1.6.4 Latin America Drug Delivery Devices Market Size (2018-2029)
1.6.5 Middle East & Africa Drug Delivery Devices Market Size (2018-2029)
2 Drug Delivery Devices Market by Type
2.1 Introduction
2.1.1 Injection Type
2.1.2 Mucosal Type
2.1.3 Implanted Type
2.1.4 Others Type
2.2 Global Drug Delivery Devices Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Drug Delivery Devices Historic Market Size by Type (2018-2023)
2.2.2 Global Drug Delivery Devices Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Drug Delivery Devices Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Drug Delivery Devices Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Drug Delivery Devices Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Drug Delivery Devices Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Drug Delivery Devices Revenue Breakdown by Type (2018-2029)
3 Drug Delivery Devices Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical Companies
3.1.2 Hospitals
3.1.3 Clinics
3.1.4 Other
3.2 Global Drug Delivery Devices Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Drug Delivery Devices Historic Market Size by Application (2018-2023)
3.2.2 Global Drug Delivery Devices Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Drug Delivery Devices Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Drug Delivery Devices Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Drug Delivery Devices Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Drug Delivery Devices Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Drug Delivery Devices Revenue Breakdown by Application (2018-2029)
4 Drug Delivery Devices Competition Analysis by Players
4.1 Global Drug Delivery Devices Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Delivery Devices as of 2022)
4.3 Date of Key Players Enter into Drug Delivery Devices Market
4.4 Global Top Players Drug Delivery Devices Headquarters and Area Served
4.5 Key Players Drug Delivery Devices Product Solution and Service
4.6 Competitive Status
4.6.1 Drug Delivery Devices Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Cipla
5.1.1 Cipla Profile
5.1.2 Cipla Main Business
5.1.3 Cipla Drug Delivery Devices Products, Services and Solutions
5.1.4 Cipla Drug Delivery Devices Revenue (US$ Million) & (2018-2023)
5.1.5 Cipla Recent Developments
5.2 Baxter International
5.2.1 Baxter International Profile
5.2.2 Baxter International Main Business
5.2.3 Baxter International Drug Delivery Devices Products, Services and Solutions
5.2.4 Baxter International Drug Delivery Devices Revenue (US$ Million) & (2018-2023)
5.2.5 Baxter International Recent Developments
5.3 Nipro Corporation
5.3.1 Nipro Corporation Profile
5.3.2 Nipro Corporation Main Business
5.3.3 Nipro Corporation Drug Delivery Devices Products, Services and Solutions
5.3.4 Nipro Corporation Drug Delivery Devices Revenue (US$ Million) & (2018-2023)
5.3.5 Roche Recent Developments
5.4 Roche
5.4.1 Roche Profile
5.4.2 Roche Main Business
5.4.3 Roche Drug Delivery Devices Products, Services and Solutions
5.4.4 Roche Drug Delivery Devices Revenue (US$ Million) & (2018-2023)
5.4.5 Roche Recent Developments
5.5 Boehringer Ingelheim
5.5.1 Boehringer Ingelheim Profile
5.5.2 Boehringer Ingelheim Main Business
5.5.3 Boehringer Ingelheim Drug Delivery Devices Products, Services and Solutions
5.5.4 Boehringer Ingelheim Drug Delivery Devices Revenue (US$ Million) & (2018-2023)
5.5.5 Boehringer Ingelheim Recent Developments
5.6 Allergan
5.6.1 Allergan Profile
5.6.2 Allergan Main Business
5.6.3 Allergan Drug Delivery Devices Products, Services and Solutions
5.6.4 Allergan Drug Delivery Devices Revenue (US$ Million) & (2018-2023)
5.6.5 Allergan Recent Developments
5.7 3M
5.7.1 3M Profile
5.7.2 3M Main Business
5.7.3 3M Drug Delivery Devices Products, Services and Solutions
5.7.4 3M Drug Delivery Devices Revenue (US$ Million) & (2018-2023)
5.7.5 3M Recent Developments
5.8 BD
5.8.1 BD Profile
5.8.2 BD Main Business
5.8.3 BD Drug Delivery Devices Products, Services and Solutions
5.8.4 BD Drug Delivery Devices Revenue (US$ Million) & (2018-2023)
5.8.5 BD Recent Developments
5.9 Catalent
5.9.1 Catalent Profile
5.9.2 Catalent Main Business
5.9.3 Catalent Drug Delivery Devices Products, Services and Solutions
5.9.4 Catalent Drug Delivery Devices Revenue (US$ Million) & (2018-2023)
5.9.5 Catalent Recent Developments
5.10 Valeant Pharmaceuticals
5.10.1 Valeant Pharmaceuticals Profile
5.10.2 Valeant Pharmaceuticals Main Business
5.10.3 Valeant Pharmaceuticals Drug Delivery Devices Products, Services and Solutions
5.10.4 Valeant Pharmaceuticals Drug Delivery Devices Revenue (US$ Million) & (2018-2023)
5.10.5 Valeant Pharmaceuticals Recent Developments
5.11 Bayer AG
5.11.1 Bayer AG Profile
5.11.2 Bayer AG Main Business
5.11.3 Bayer AG Drug Delivery Devices Products, Services and Solutions
5.11.4 Bayer AG Drug Delivery Devices Revenue (US$ Million) & (2018-2023)
5.11.5 Bayer AG Recent Developments
5.12 Chiesi
5.12.1 Chiesi Profile
5.12.2 Chiesi Main Business
5.12.3 Chiesi Drug Delivery Devices Products, Services and Solutions
5.12.4 Chiesi Drug Delivery Devices Revenue (US$ Million) & (2018-2023)
5.12.5 Chiesi Recent Developments
5.13 Phillips-Medisize
5.13.1 Phillips-Medisize Profile
5.13.2 Phillips-Medisize Main Business
5.13.3 Phillips-Medisize Drug Delivery Devices Products, Services and Solutions
5.13.4 Phillips-Medisize Drug Delivery Devices Revenue (US$ Million) & (2018-2023)
5.13.5 Phillips-Medisize Recent Developments
5.14 Johnson & Johnson
5.14.1 Johnson & Johnson Profile
5.14.2 Johnson & Johnson Main Business
5.14.3 Johnson & Johnson Drug Delivery Devices Products, Services and Solutions
5.14.4 Johnson & Johnson Drug Delivery Devices Revenue (US$ Million) & (2018-2023)
5.14.5 Johnson & Johnson Recent Developments
5.15 Shandong Weigao
5.15.1 Shandong Weigao Profile
5.15.2 Shandong Weigao Main Business
5.15.3 Shandong Weigao Drug Delivery Devices Products, Services and Solutions
5.15.4 Shandong Weigao Drug Delivery Devices Revenue (US$ Million) & (2018-2023)
5.15.5 Shandong Weigao Recent Developments
5.16 Pfizer
5.16.1 Pfizer Profile
5.16.2 Pfizer Main Business
5.16.3 Pfizer Drug Delivery Devices Products, Services and Solutions
5.16.4 Pfizer Drug Delivery Devices Revenue (US$ Million) & (2018-2023)
5.16.5 Pfizer Recent Developments
5.17 B.Braun
5.17.1 B.Braun Profile
5.17.2 B.Braun Main Business
5.17.3 B.Braun Drug Delivery Devices Products, Services and Solutions
5.17.4 B.Braun Drug Delivery Devices Revenue (US$ Million) & (2018-2023)
5.17.5 B.Braun Recent Developments
5.18 Novartis AG
5.18.1 Novartis AG Profile
5.18.2 Novartis AG Main Business
5.18.3 Novartis AG Drug Delivery Devices Products, Services and Solutions
5.18.4 Novartis AG Drug Delivery Devices Revenue (US$ Million) & (2018-2023)
5.18.5 Novartis AG Recent Developments
5.19 Zhengkang
5.19.1 Zhengkang Profile
5.19.2 Zhengkang Main Business
5.19.3 Zhengkang Drug Delivery Devices Products, Services and Solutions
5.19.4 Zhengkang Drug Delivery Devices Revenue (US$ Million) & (2018-2023)
5.19.5 Zhengkang Recent Developments
5.20 Gerresheimer
5.20.1 Gerresheimer Profile
5.20.2 Gerresheimer Main Business
5.20.3 Gerresheimer Drug Delivery Devices Products, Services and Solutions
5.20.4 Gerresheimer Drug Delivery Devices Revenue (US$ Million) & (2018-2023)
5.20.5 Gerresheimer Recent Developments
5.21 COVIDIEN Medtronic
5.21.1 COVIDIEN Medtronic Profile
5.21.2 COVIDIEN Medtronic Main Business
5.21.3 COVIDIEN Medtronic Drug Delivery Devices Products, Services and Solutions
5.21.4 COVIDIEN Medtronic Drug Delivery Devices Revenue (US$ Million) & (2018-2023)
5.21.5 COVIDIEN Medtronic Recent Developments
5.22 Schott forma vitrum
5.22.1 Schott forma vitrum Profile
5.22.2 Schott forma vitrum Main Business
5.22.3 Schott forma vitrum Drug Delivery Devices Products, Services and Solutions
5.22.4 Schott forma vitrum Drug Delivery Devices Revenue (US$ Million) & (2018-2023)
5.22.5 Schott forma vitrum Recent Developments
5.23 Alkermes
5.23.1 Alkermes Profile
5.23.2 Alkermes Main Business
5.23.3 Alkermes Drug Delivery Devices Products, Services and Solutions
5.23.4 Alkermes Drug Delivery Devices Revenue (US$ Million) & (2018-2023)
5.23.5 Alkermes Recent Developments
5.24 Skyepharma
5.24.1 Skyepharma Profile
5.24.2 Skyepharma Main Business
5.24.3 Skyepharma Drug Delivery Devices Products, Services and Solutions
5.24.4 Skyepharma Drug Delivery Devices Revenue (US$ Million) & (2018-2023)
5.24.5 Skyepharma Recent Developments
6 North America
6.1 North America Drug Delivery Devices Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Drug Delivery Devices Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Drug Delivery Devices Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Drug Delivery Devices Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Drug Delivery Devices Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Drug Delivery Devices Market Dynamics
11.1 Drug Delivery Devices Industry Trends
11.2 Drug Delivery Devices Market Drivers
11.3 Drug Delivery Devices Market Challenges
11.4 Drug Delivery Devices Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
